Charles Schwab’s Treace Medical Concepts TMCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$441K	Sell	328,839 -23,605	-7%	-$47K	﹤0.01%	3141
2025 Q4	$863K	Sell	352,444 -62,562	-15%	-$272K	﹤0.01%	2980
2025 Q3	$2.78M	Buy	415,006 +60,567	+17%	+$395K	﹤0.01%	2670
2025 Q2	$2.08M	Sell	354,439 -25,972	-7%	-$169K	﹤0.01%	2654
2025 Q1	$3.19M	Buy	380,411 +30,901	+9%	+$278K	﹤0.01%	2459
2024 Q4	$2.6M	Sell	349,510 -41,523	-11%	-$278K	﹤0.01%	2599
2024 Q3	$2.27M	Buy	391,033 +17,783	+5%	+$114K	﹤0.01%	2667
2024 Q2	$2.48M	Buy	373,250 +14,900	+4%	+$120K	﹤0.01%	2629
2024 Q1	$4.68M	Buy	358,350 +2,530	+0.7%	+$33.7K	﹤0.01%	2311
2023 Q4	$4.54M	Buy	355,820 +19,571	+6%	+$198K	﹤0.01%	2354
2023 Q3	$4.41M	Buy	336,249 +51,892	+18%	+$950K	﹤0.01%	2312
2023 Q2	$7.27M	Buy	284,357 +21,119	+8%	+$545K	﹤0.01%	2062
2023 Q1	$6.63M	Buy	263,238 +24,151	+10%	+$567K	﹤0.01%	2066
2022 Q4	$5.5M	Buy	239,087 +5,208	+2%	+$120K	﹤0.01%	2166
2022 Q3	$5.16M	Buy	233,879 +101,106	+76%	+$1.96M	﹤0.01%	2204
2022 Q2	$1.9M	Buy	132,773 +7,052	+6%	+$119K	﹤0.01%	2579
2022 Q1	$2.38M	Buy	125,721 +3,265	+3%	+$63.5K	﹤0.01%	2586
2021 Q4	$2.28M	Buy	122,456 +41,867	+52%	+$864K	﹤0.01%	2663
2021 Q3	$2.17M	Buy	80,589 +1,832	+2%	+$50.4K	﹤0.01%	2684
2021 Q2	$2.46M	Buy	+78,757	New	+$2.51M	﹤0.01%	2641